These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles. Pai Kasturi S; Qin H; Thomson KS; El-Bereir S; Cha SC; Neelapu S; Kwak LW; Roy K J Control Release; 2006 Jul; 113(3):261-70. PubMed ID: 16793161 [TBL] [Abstract][Full Text] [Related]
5. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity. Sun Y; Peng D; Lecanda J; Schmitz V; Barajas M; Qian C; Prieto J Gene Ther; 2000 Sep; 7(17):1467-76. PubMed ID: 11001366 [TBL] [Abstract][Full Text] [Related]
6. [Construction of a DNA vaccine against human B cell lymphoma]. Zhang YS; Zhong KL; Yuan Y; Zhang MW; Zhang Y; Mao N Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan; 20(1):79-82. PubMed ID: 15182628 [TBL] [Abstract][Full Text] [Related]
7. A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF). Lima J; Jenkins C; Guerrero A; Triozzi PL; Shaw DR; Strong TV Vaccine; 2005 Jan; 23(10):1273-83. PubMed ID: 15652670 [TBL] [Abstract][Full Text] [Related]
8. Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains. Ferrone CR; Perales MA; Goldberg SM; Somberg CJ; Hirschhorn-Cymerman D; Gregor PD; Turk MJ; Ramirez-Montagut T; Gold JS; Houghton AN; Wolchok JD Clin Cancer Res; 2006 Sep; 12(18):5511-9. PubMed ID: 17000687 [TBL] [Abstract][Full Text] [Related]
9. [Active immunity for anti-colorectal cancer induced by chemokine MCP-3 gene transfection]. Hu JY; Li GC; Zhu JG; Wang WM; Li YH; Zhou GH; Sun QB Ai Zheng; 2002 May; 21(5):504-8. PubMed ID: 12452041 [TBL] [Abstract][Full Text] [Related]
10. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity. Aarts WM; Schlom J; Hodge JW Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537 [TBL] [Abstract][Full Text] [Related]
11. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
13. Vaccine therapy of established tumors in the absence of autoimmunity. Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742 [TBL] [Abstract][Full Text] [Related]
14. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response. Flanagan K; Glover RT; Hörig H; Yang W; Kaufman HL Vaccine; 2004 Jul; 22(21-22):2894-903. PubMed ID: 15246626 [TBL] [Abstract][Full Text] [Related]
15. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814 [TBL] [Abstract][Full Text] [Related]
16. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity. Todo T; Martuza RL; Dallman MJ; Rabkin SD Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154 [TBL] [Abstract][Full Text] [Related]
17. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma. Sloots A; Mastini C; Rohrbach F; Weth R; Curcio C; Burkhardt U; Jäger E; Forni G; Cavallo F; Wels WS Clin Cancer Res; 2008 Nov; 14(21):6933-43. PubMed ID: 18980988 [TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy. Stagg J; Wu JH; Bouganim N; Galipeau J Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547 [TBL] [Abstract][Full Text] [Related]
20. Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21. Yamano T; Kaneda Y; Hiramatsu SH; Huang S; Tran AN; Giuliano AE; Hoon DS Cancer Gene Ther; 2007 May; 14(5):451-9. PubMed ID: 17318199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]